← Open Payments lookup

NICHOLAS RYSER: Open Payments

NPI 1376193151 · VANCOUVER, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$689 in 38 payments from 14 companies in 2025. Trend: 2023 $1,057 · 2024 $1,294 · 2025 $689

Food & beverage: $689
CompanyPaymentsAmount
ABBVIE INC.15$208
Madrigal Pharmaceuticals6$154
GENZYME CORPORATION4$76
Regeneron Healthcare Solutions, Inc.3$58
Janssen Biotech, Inc.1$28
Ipsen Biopharmaceuticals, Inc1$24
Celltrion USA Inc.1$23
Mallinckrodt Hospital Products Inc.1$21
TerSera Therapeutics LLC1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: REZDIFFRA, DUPIXENT, RINVOQ, SKYRIZI, TREMFYA, VEGZELMA, TERLIVAZ, Xermelo.

Industry payments across WA — which companies pay providers there.